Harnessing the immune system to fight triple negative breast cancer
Women with triple negative breast cancer (TNBC) learn quickly that their aggressive form of the disease is notoriously resistant to the standard treatments of surgery, radiation, and chemotherapy.
That's why the Vera Bradley Foundation Center for Breast Cancer Research is focusing on advancing the science of immunotherapy—using the body's immune system to target and destroy even the toughest cancer cells.